Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting - Seite 2

Other Products Debuting at AOFAS

Also being introduced at AOFAS is Prophecy Footprint, an add-on service to Stryker’s Prophecy Surgical Planning system that provides an understanding of the ancillary procedures to be considered for patients needing total ankle replacement surgery with concomitant pathology. Prophecy Footprint is currently in limited release in the U.S., with plans for a full launch next year.

“We also look forward to introducing Prophecy Footprint at AOFAS, which will change the way surgeons prepare and plan for total ankle cases,” said Rankin. “In order to have a successful total ankle surgery, you have to consider what is going on with the foot itself. By facilitating a more comprehensive view of the foot around the ankle, Footprint can help surgeons with their most complex patient populations.”

Rounding out its offering for foot and ankle procedures, Stryker will showcase the CurveBeam AI HiRise weight-bearing computerized tomography (WBCT) imaging system at AOFAS. Stryker’s Foot & Ankle business has entered into an exclusive co-promotion and distribution agreement with CurveBeam AI, a leader in WBCT. This exclusive agreement will offer a turnkey surgical solution for our foot and ankle surgeon customers treating complex deformities.

Stryker will offer product demonstrations and a virtual reality experience at AOFAS at booth #103 for more information.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at www.stryker.com.

The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220914005257/en/

The Stryker Stock at the time of publication of the news with a raise of +0,11 % to 226,5EUR on Tradegate stock exchange (14. September 2022, 13:59 Uhr).